Expression of human α-galactosidase leads to reduction of major xenoepitope Galα(1,3) Gal in NIH 3T3 cell

Acta Pharmacologica Sinica

Volumn 24, Issue 10, 2003, Pages 985-990+1060

  Yan, Jing Lian ^a   Yu, Lu Yang ^a   Zhu, Li Hua ^a   Guo, Li He ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Gal epitope; Human galactosidase; NIH 3T3 cell; Xenotransplantation

Indexed keywords

ALPHA GALACTOSIDASE; ANTIGEN; COMPLEMENT COMPONENT C3C; EPITOPE; G ANTIGEN; GALACTOSYL ALPHA 1,3 GALACTOSIDASE; GLYCOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CELL MEMBRANE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNOREACTIVITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; XENOTRANSPLANTATION;

ALPHA-GALACTOSIDASE; ANIMALS; CELL MEMBRANE; CLONING, MOLECULAR; DISACCHARIDES; DNA, COMPLEMENTARY; GRAFT REJECTION; HUMANS; MICE; NIH 3T3 CELLS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0141960899     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bishop DF, Kornreich R, Eng CM. Human α-galactosidase: characterization and eukaryotic expression of the full-length cDNA and structural organization of the gene. In: Salvayre R, Douste-Blazy L, Gatt S, editors. Lipid storage disorders. New York: Plenum Publishing Corp; 1988. p809-20.
2. Ohshima T, Murray GJ, Nagle JW, Quirk JM, Kraus MH, Barton NW, et al. Structural organization and expression of the mouse gene encoding A. Gene 1995; 166: 277-80
3. Zhu A, Wang ZK. Expression and characterization of recombinant α-galactosidase in baculovirus-infected insect cells. Eur J Biochem 1996; 235: 332-7.
4. Zhu A, Goldstein J. Cloning and functional expression of a cDNA encoding coffee bean á-galactosidase. Gene 1994; 140: 227-31.
5. Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human α-galactosidase A gene: further evidence for the absence of a 3′ untranslated region. Proc Natl Acad Sci USA 1988; 85: 3903-7.
6. Takenaka T, Murray GJ, Qin GJ, Quirk JM, Ohshima T, Qasba P, et al. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc Natl Acad Sci USA 2000; 97: 7515-20.
7. Jung SC, Han IP, Limaye A, Xu R, Gelderman MP, Zerfas P, et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA 2001; 98: 2676-81.
8. Qin GJ, Takenaka T, Telsch K, Kelley L, Howard T, Levade T, et al. Preselective gene therapy for Fabry disease. Proc Natl Acad Sci USA 2001; 98: 3428-33.
9. Goldstein J, Siviglia G, Hurst R, Lenny L, Reich L. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals. Science 1982; 215: 168-70.
10. Zhu A, Leng L, Monahan C, Zhang Z, Hurst R, Lenny L, et al. Characterization of recombinant α-galactosidase for use in seroconversion from blood group B to O of human erythrocytes. Arch Biochem Biophys 1996; 327: 324-9.
11. Osman N, Mckenzie IFC, Ostenried K, Ioannou YA, Desnick RJ, Sandrin MS. Combined transgenic expression of α-galactosidase and α(1,2) fucosyltransferase leads to optimal reduction in the major xenoepitope Gal α(1,3) Gal. Proc Natl Acad Sci USA 1997; 94: 14677-82.
12. Galili U. Interaction of the natural anti-gal antibody with a-galactosyl epitopes: a major obstacle of xenotransplantation in humans. Immunol Today 1993; 14: 480-6.
13. Good H, Cooper DKC, Malcolm AJK, Ippolito RM, Koren E, Neethling FA, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant grafting in man. Transplant Proc 1992; 24: 559-62.
14. Sandrin M, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal α1,3 Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391-5.
15. Shinkel TA, Chen CG, Salvaris E, Henion TR, Barlow H, Galili U, et al. Changes in cell surface glycosylation in α 1,3-galactosyltransferase knock out and α(1,2) fucosyltransferase transgenic mice. Transplantation 1997; 64: 197-204.
16. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, et al. Reduction in the level of Gal α(1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190-5.
17. Koike C, Katayama K, Muramatsu T. Direct gene replacement of the mouse α(1, 3)-galactosyltransferase gene with human α (1,2)-fucosyltransferase gene: converting α-galactosyl epitopes into H antigens. Xenotransplantation 1997; 4: 147-53.
18. Kujundzic M, Koren E, Neethling FA. Variability of anti-Gal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994; 1: 58.
19. Parker W, Bruno O, Holzkecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive human natural antibodies. J Immunol 1994; 153: 3791-803.
20. Gambiez L, Salame E, Chereau C, Calmus Y, Cardoso J, Ayani E, et al. The role of natural IgM in the hyperacute rejection of discordant heart xenografts. Transplantation 1992; 54: 577-83.
21. Dehoux J P, Hori S, Talpe S, Bazin H, Latinne D, Soares MP, et al. Specific depletion of preformed IgM natural antibodies by administration of anti-μ monoclonal antibody suppresses hyperacute rejection of pig to baboon renal xenografts. Transplantation 2000; 70: 935-46.
22. Good AH, Cooper DKC, Malcolm AJ, Ippolito RM, Koren E, Neethling FA,et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implication for discordant xenografting in man. Transplant Proc 1992; 24: 559-62.
23. Collins Bh, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W, et al. Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute reaction. J Immunol 1995; 154: 5500-10.
24. Schraa EO, Stockmann HBAC, Broekhuizen AJ, Scheringa M, Schuurman HJ, Marquet RL, et al. IgG, but not IgM, mediates hyperacute rejection in hepatic xenografting. Xenotransplantation 1999; 6: 110-6.
25. Galili U, Minanov U, Michler R E. High affinity anti-Gal IgG in chronic rejection of xenografts. Xenotransplantation 1997; 4: 127-9.
26. Tanemura M, Maruyama S, Galili U. Differential expression of α-Gal epitopes (Galαl-3Galβ1-4GlcNAc-R) on pig and mouse organs. Transplantation 2000; 69: 187-90.
27. Yan JL, Yu LY, Guo LH. Human alpha galactosidase and alpha 1,2 fucosyltransferase concordantly inhibit xenoreactivity of NIH 3T3 cells with human serum. Acta Pharmacol Sin 2003; 24: 878-84.